Simplex Trading
JAZZ icon

Simplex Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History

Simplex Trading’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$605K Sell
3,200
-2,300
-42% -$402K ﹤0.01% 3054
2025
Q4 		$935K Buy
5,500
+4,500
+450% +$690K ﹤0.01% 2691
2025
Q3 		$131K Buy
1,000
+200
+25% +$24K ﹤0.01% 5445
2025
Q2 		$84K Sell
800
-5,100
-86% -$554K ﹤0.01% 5405
2025
Q1 		$732K Buy
5,900
+5,200
+743% +$678K ﹤0.01% 3001
2024
Q4 		$86K Sell
700
-2,300
-77% -$271K ﹤0.01% 5327
2024
Q3 		$334K Buy
3,000
+1,200
+67% +$132K ﹤0.01% 4023
2024
Q2 		$192K Sell
1,800
-5,300
-75% -$583K ﹤0.01% 4693
2024
Q1 		$854K Sell
7,100
-5,600
-44% -$686K ﹤0.01% 3290
2023
Q4 		$1.56M Buy
12,700
+1,800
+17% +$225K ﹤0.01% 2576
2023
Q3 		$1.41M Buy
10,900
+9,400
+627% +$1.25M ﹤0.01% 2361
2023
Q2 		$185K Sell
1,500
-400
-21% -$53.8K ﹤0.01% 4387
2023
Q1 		$278K Sell
1,900
-10,700
-85% -$1.58M ﹤0.01% 3930
2022
Q4 		$255K Sell
12,600
-15,700
-55% -$2.3M ﹤0.01% 3921
2022
Q3 		$3.77M Sell
28,300
-2,100
-7% -$319K ﹤0.01% 1415
2022
Q2 		$4.74M Sell
30,400
-700
-2% -$108K 0.01% 1181
2022
Q1 		$4.84M Sell
31,100
-1,300
-4% -$189K ﹤0.01% 1269
2021
Q4 		$4.13M Sell
32,400
-9,600
-23% -$1.26M ﹤0.01% 1367
2021
Q3 		$7.61M Hold
42,000
– – 0.01% 888
2021
Q2 		$7.46M Buy
42,000
+41,795
+20,388% +$7.24M 0.01% 884
2021
Q1 		$3.37M Sell
205
-33
-14% -$5.43K 0.01% 1136
2020
Q4 		$3.93M Buy
238
+81
+52% +$12.1K 0.01% 1169
2020
Q3 		$2.24M Buy
157
+106
+208% +$13.1K ﹤0.01% 1440
2020
Q2 		$562K Buy
51
+5
+11% +$553 ﹤0.01% 2764
2020
Q1 		$458K Sell
46
-155
-77% -$20K ﹤0.01% 2690
2019
Q4 		$3M Buy
201
+5
+3% +$680 0.01% 1156
2019
Q3 		$2.51M Buy
196
+185
+1,682% +$24.8K 0.01% 1158
2019
Q2 		$156K Sell
11
-178
-94% -$23.9K ﹤0.01% 3718
2019
Q1 		$2.7M Buy
189
+171
+950% +$22.3K 0.01% 1110
2018
Q4 		$223K Sell
18
-127
-88% -$18.8K ﹤0.01% 3044
2018
Q3 		$2.44M Buy
145
+21
+17% +$3.61K 0.01% 1084
2018
Q2 		$2.14M Buy
124
+104
+520% +$17K 0.01% 1087
2018
Q1 		$6K Sell
20
-81
-80% -$11.9K ﹤0.01% 4486
2017
Q4 		$21K Sell
101
-88
-47% -$12.2K ﹤0.01% 3259
2017
Q3 		$44K Buy
189
+15
+9% +$2.27K ﹤0.01% 2416
2017
Q2 		$53K Sell
174
-206
-54% -$31.5K ﹤0.01% 2343
2017
Q1 		$36K Buy
380
+292
+332% +$38K ﹤0.01% 2664
2016
Q4 		$189K Buy
88
+17
+24% +$1.89K 0.01% 1087
2016
Q3 		$149K Buy
71
+23
+48% +$3.1K 0.01% 1245
2016
Q2 		$49K Buy
48
+5
+12% +$737 ﹤0.01% 2074
2016
Q1 		$76K Sell
43
-48
-53% -$5.97K 0.01% 1577
2015
Q4 		$71K Sell
91
-15
-14% -$2.08K 0.01% 1629
2015
Q3 		$307K Buy
106
+64
+152% +$11K 0.02% 678
2015
Q2 		$8K Sell
42
-21
-33% -$3.77K ﹤0.01% 3254
2015
Q1 		$11K Buy
+63
New +$10.8K ﹤0.01% 2872

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Simplex Trading's JAZZ Position: Q1 2026 in Review

Simplex Trading sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 3,042 shares — an estimated $532K sold.

Simplex Trading first reported a position in JAZZ in Q4 2014 and held it in 25 quarters. The position peaked at $2.6M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Simplex Trading reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 3,042 Jazz Pharmaceuticals shares in Q1 2026, an estimated $532K.
  • Simplex Trading first reported a position in Jazz Pharmaceuticals in Q4 2014 and held it in 25 quarters.
  • Simplex Trading's Jazz Pharmaceuticals position peaked at $2.6M in Q1 2022.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.